Hepatitis C virus fusion proteins
US5854001A · kind A · utility
14Cited by
2References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 18, 1996 |
| Grant date | Dec 29, 1998 |
| Priority date | — |
| Expiry date | Sep 18, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/24222
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Mammalian expression systems for the production of HCV fusion proteins. Such expression systems provide high yields of HCV fusion proteins, and enable the development of diagnostic and therapeutic reagents which contain glycosylated structural antigens and also allow for the isolation of the HCV etiological agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.